On September 4, 2012, Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) received a letter from The NASDAQ Stock Market ("NASDAQ") notifying it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE